Tibra Equities Europe’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-34,458
Closed -$655K 535
2019
Q1
$655K Buy
+34,458
New +$559K 0.07% 233

Other funds holding OSIR

Tibra Equities Europe's OSIR Position: Q2 2019 in Review

Tibra Equities Europe sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 34,458 shares — an estimated $655K sold.

Tibra Equities Europe first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $655K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Tibra Equities Europe reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 34,458 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $655K.
  • Tibra Equities Europe first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Tibra Equities Europe's Osiris Therapeutics, Inc. Common Stock position peaked at $655K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Tibra Equities Europe's 13F filing for Q2 2019, filed 1 Aug 2019.